BACK TO CONTENTS     |      PDF     |      PREVIOUS     |      NEXT

Title

A 3D-QSAR model based screen for dihydropyridine-like compound library to identify inhibitors of amyloid beta (Aβ) production

 

Authors

Venkatarajan S Mathura*, Nikunj Patel, Corbin Bachmeier, Michael Mullan, Daniel Paris

 

Affiliation

Roskamp Institute, 2040 Whitfield Avenue, Sarasota, FL 34243, USA.

E-mail*

venkat@rfdn.org; *Corresponding author

Article Type

 

Hypothesis

 

Date

 

Received July 11, 2010; Accepted August 11, 2010; Published September 20, 2010

 

Abstract

 

Abnormal accumulation of amyloid beta peptide (Aβ) is one of the hallmarks of Alzheimer's disease progression. Practical limitations such as cost , poor hit rates and a lack of well characterized targets are a major bottle neck in the in vitro screening of a large number of chemical libraries and profiling them to
identify Aβ inhibitors. We used a limited set of 1,4 dihydropyridine (DHP)-like compounds from our model set (MS) of 24 compounds which inhibit Aβ as a training set and built 3D-QSAR (Three-dimensional Quantitative Structure-Activity Relationship) models using the Phase program (SchrÖdinger, USA). We developed a 3D-QSAR model that showed the best prediction for Aβ inhibition in the test set of compounds and used this model to screen a 1,043 DHP-like small library set of (LS) compounds. We found that our model can effectively predict potent hits at a very high rate and result in significant cost savings when screening larger libraries. We describe here our in silico model building strategy, model selection parameters and the chemical features that are useful for successful screening of DHP and DHP-like chemical libraries for Aß inhibitors.

Keywords

 

3D-QSAR, β-amyloid, in silico screening, dihydropyridine, Alzheimer's Disease

Citation

 

Mathura et al. Bioinformation 5(3): 122-127 (2010)

Edited by

 

P. Kangueane

 

ISSN

 

0973-2063

 

Publisher

 

Biomedical Informatics

 

License

 

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.